Study to assess the Efficacy of the Chimeric Dopamine-Somatostatin receptor agonist, TBR-760, in adult patients with Non-Functioning Pituitary Adenoma over 52 weeks.
NFPA status-post one TSS with a NFPA remnant of ≥ 10mm
Has undergone more than one TSS
Has undergone radiation therapy to the head for any reason
Any contraindications to magnetic resonance imaging